Turkey
Hepatitis B
Download HBV dataPrevalence of chronic HBV (HBsAg+)
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
3 | 2003 | Survey/reported | Ozsoy MF et al, 2003 |
2.5 | 2009 | Survey/reported | Akcama FZ et al, 2009 |
2.63 (2.08 - 3.28) | 2015 | Modelled | WHO |
2.6 (1.90 - 3.50) | 2016 | Modelled | Razavi-Shearer et al, 2018 |
4 (3.99 - 4.02) | 2013 | Modelled | Schweitzer et al, 2015 |
2.43 (2.31 - 2.56) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
2.74 (2.61 - 2.88) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.81 (2.66 - 2.97) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.85 (2.71 - 2.99) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.88 (2.74 - 3.04) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.93 (2.79 - 3.08) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
3 (2.86 - 3.16) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.08 (2.93 - 3.24) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.15 (3 - 3.33) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.21 (3.04 - 3.40) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.27 (3.10 - 3.45) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.35 (3.19 - 3.53) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.44 (3.27 - 3.62) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.52 (3.35 - 3.71) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.59 (3.41 - 3.79) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.66 (3.48 - 3.86) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.75 (3.56 - 3.95) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.85 (3.66 - 4.07) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.96 (3.74 - 4.19) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.04 (3.80 - 4.30) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.13 (3.89 - 4.39) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.24 (3.99 - 4.49) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.35 (4.09 - 4.60) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.46 (4.18 - 4.73) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.54 (4.23 - 4.83) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.61 (4.32 - 4.89) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.67 (4.39 - 4.95) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.73 (4.46 - 5.01) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.79 (4.51 - 5.07) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.84 (4.54 - 5.14) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.61 (2.49 - 2.75) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
Children under-5 years
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0.32 (0.22 - 0.48) | 2015 | Modelled | WHO |
0.17 (0.14 - 0.20) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
0.21 (0.17 - 0.25) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.23 (0.19 - 0.27) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.24 (0.20 - 0.29) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.25 (0.21 - 0.29) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.26 (0.22 - 0.31) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.28 (0.23 - 0.33) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.3 (0.25 - 0.35) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.31 (0.26 - 0.37) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.34 (0.28 - 0.40) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.37 (0.31 - 0.43) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.41 (0.34 - 0.48) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.48 (0.40 - 0.56) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.56 (0.47 - 0.66) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.66 (0.55 - 0.77) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.77 (0.64 - 0.90) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.89 (0.74 - 1.04) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.04 (0.88 - 1.22) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.22 (1.03 - 1.44) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.42 (1.21 - 1.69) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.66 (1.39 - 1.97) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.04 (1.72 - 2.40) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.58 (2.18 - 3.02) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.15 (2.66 - 3.68) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.63 (3.03 - 4.24) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.89 (3.23 - 4.56) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.99 (3.32 - 4.67) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.06 (3.39 - 4.79) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.12 (3.44 - 4.89) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.14 (3.47 - 4.94) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.14 (3.46 - 4.93) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.11 (0.09 - 0.13) | 2020 | Modelled | WHO |
Showing out of
Show more
People who inject drugs (PWID)
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
3.86 | 2015 | Survey/reported | EMCDDA; General Directorate of Health Service |
4.21 | 2014 | Survey/reported | EMCDDA; General Directorate of Health Service |
4.52 | 2013 | Survey/reported | EMCDDA; General Directorate of Health Service |
8.6 | 2012 | Survey/reported | EMCDDA; General Directorate of Health Service |
7.5 | 2011 | Survey/reported | EMCDDA; General Directorate of Health Service |
3.56 | 2010 | Survey/reported | EMCDDA; General Directorate of Health Service |
5.24 | 2009 | Survey/reported | EMCDDA; General Directorate of Health Service |
8 | 2008 | Survey/reported | EMCDDA; General Directorate of Health Service |
19.28 | 2007 | Survey/reported | EMCDDA; General Directorate of Health Service |
17.93 | 2006 | Survey/reported | EMCDDA; General Directorate of Health Service |
Showing out of
Show more
Number of people living with chronic HBV
National
DownloadValue | Year | Type | Source |
---|---|---|---|
2,091,000 (1,536,000 - 2,786,000) | 2016 | Modelled | Razavi-Shearer et al, 2018 |
1,976,310 (1,881,680 - 2,082,750) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
2,042,400 (1,943,170 - 2,149,030) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,131,330 (2,029,040 - 2,239,600) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,177,830 (2,064,600 - 2,297,360) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,187,020 (2,080,580 - 2,295,700) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,193,220 (2,086,350 - 2,308,060) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,204,830 (2,098,910 - 2,317,980) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,224,200 (2,117,420 - 2,338,450) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,247,870 (2,138,930 - 2,366,390) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,274,760 (2,159,210 - 2,398,640) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,296,240 (2,175,840 - 2,428,470) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,323,930 (2,204,910 - 2,451,040) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,366,600 (2,251,670 - 2,492,680) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,412,750 (2,300,740 - 2,542,160) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,454,680 (2,336,280 - 2,591,980) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,484,750 (2,363,810 - 2,626,450) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,514,880 (2,394,020 - 2,649,160) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,556,400 (2,428,540 - 2,694,410) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,601,120 (2,465,920 - 2,742,500) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,643,170 (2,500,820 - 2,797,430) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,674,970 (2,520,490 - 2,845,860) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,704,570 (2,547,740 - 2,868,520) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,741,540 (2,583,920 - 2,902,240) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,777,930 (2,611,420 - 2,939,060) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,805,800 (2,631,780 - 2,977,190) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,816,860 (2,634,590 - 2,995,110) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,815,040 (2,641,960 - 2,988,570) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,809,580 (2,645,200 - 2,974,860) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,799,700 (2,639,210 - 2,968,560) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,784,680 (2,624,990 - 2,949,760) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,763,560 (2,604,450 - 2,935,890) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
HBV-related death rate
National
DownloadValue (per 100,000) | Year | Type | Source |
---|---|---|---|
4.34 (3.25 - 5.68) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
6.39 (4.96 - 7.86) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
6.5 (5.09 - 7.90) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
6.65 (5.30 - 8) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
6.74 (5.40 - 8.08) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
6.57 (5.19 - 7.92) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
6.75 (5.43 - 8.03) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
6.67 (5.44 - 7.91) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
6.66 (5.51 - 7.93) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
6.56 (5.40 - 7.76) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
6.38 (5.33 - 7.50) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
6.04 (5.09 - 7.10) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
6 (5.05 - 7.11) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
6.07 (5.14 - 7.21) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
5.8 (4.80 - 7.05) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
5.3 (4.29 - 6.49) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
5.61 (4.59 - 6.83) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
5.45 (4.45 - 6.66) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
5.07 (4.10 - 6.20) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.84 (3.96 - 5.84) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.66 (3.87 - 5.56) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.55 (3.76 - 5.40) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.55 (3.80 - 5.39) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.51 (3.77 - 5.39) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.53 (3.77 - 5.41) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.51 (3.76 - 5.34) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.52 (3.72 - 5.47) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.36 (3.51 - 5.40) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.24 (3.31 - 5.40) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.26 (3.26 - 5.53) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
4.34 (3.25 - 5.68) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
HBV-related deaths
National
DownloadValue | Year | Type | Source |
---|---|---|---|
4,200 | 2016 | Modelled | WHO |
3,819 (2,966 - 4,696) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,957 (3,101 - 4,811) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
4,193 (3,342 - 5,038) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
4,073 (3,215 - 4,912) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
4,311 (3,453 - 5,171) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
4,382 (3,525 - 5,215) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
4,395 (3,588 - 5,210) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
4,452 (3,678 - 5,296) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
4,437 (3,652 - 5,254) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
4,181 (3,527 - 4,919) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
4,371 (3,648 - 5,134) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
4,292 (3,632 - 5,097) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
4,198 (3,535 - 4,974) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
4,140 (3,425 - 5,029) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
4,035 (3,301 - 4,912) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,869 (3,135 - 4,740) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,726 (3,011 - 4,560) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,950 (3,228 - 4,832) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,581 (2,930 - 4,316) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,464 (2,875 - 4,131) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,404 (2,813 - 4,037) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,427 (2,864 - 4,060) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,490 (2,913 - 4,164) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,434 (2,862 - 4,072) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,557 (2,955 - 4,247) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,494 (2,812 - 4,329) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,583 (2,953 - 4,337) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,417 (2,670 - 4,353) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,454 (2,642 - 4,483) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,530 (2,645 - 4,618) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,530 (2,645 - 4,618) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
Showing out of
Show more
Percent of liver cancer deaths attributable to HBV
National
Download
Showing out of
Show more
Coverage of HepB birth dose
Newborns
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
99 | 2019 | Survey/reported | WHO/UNICEF |
99 | 2018 | Survey/reported | WHO/UNICEF |
99 | 2017 | Survey/reported | WHO/UNICEF |
99 | 2016 | Survey/reported | WHO/UNICEF |
99 | 2015 | Survey/reported | WHO/UNICEF |
99 | 2014 | Survey/reported | WHO/UNICEF |
99 | 2013 | Survey/reported | WHO/UNICEF |
97 | 2012 | Survey/reported | WHO/UNICEF |
97 | 2011 | Survey/reported | WHO/UNICEF |
97 | 2010 | Survey/reported | WHO/UNICEF |
96 | 2009 | Survey/reported | WHO/UNICEF |
96 | 2008 | Survey/reported | WHO/UNICEF |
96 | 2007 | Survey/reported | WHO/UNICEF |
95 | 2006 | Survey/reported | WHO/UNICEF |
94 | 2005 | Survey/reported | WHO/UNICEF |
88 | 2004 | Survey/reported | WHO/UNICEF |
78 | 2003 | Survey/reported | WHO/UNICEF |
99 | 2020 | Survey/reported | WHO/UNICEF |
99 | 2021 | Survey/reported | WHO/UNICEF |
Showing out of
Show more
Coverage of 3-dose hepatitis B vaccine
Infants
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
99 | 2019 | Survey/reported | WHO/UNICEF |
98 | 2020 | Survey/reported | WHO/UNICEF |
96 | 2021 | Survey/reported | WHO/UNICEF |
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
DownloadValue | Year | Type | Source |
---|---|---|---|
0 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
HBV National Action Plan
HBV elimination goal
HBV testing policy
Pregnant women, Risk-based
HepB birth dose policy
Yes
Year of birth dose introduction
2003
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
HCV testing policy
Risk-based
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)
Hepatitis C
Download HCV dataPrevalence of chronic HCV (RNA+/cAg)
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0.6 (0.30 - 1) | 2015 | Modelled | Blach et al, 2017 |
1.04 (0.86 - 1.29) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.88 (0.72 - 1.06) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.8 (0.66 - 0.95) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.81 (0.69 - 0.95) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.83 (0.71 - 0.96) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.82 (0.71 - 0.95) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.82 (0.71 - 0.94) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.81 (0.71 - 0.92) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.8 (0.70 - 0.91) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.79 (0.69 - 0.90) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.78 (0.69 - 0.89) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.77 (0.67 - 0.88) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.76 (0.66 - 0.86) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.74 (0.65 - 0.84) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.73 (0.64 - 0.83) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.72 (0.63 - 0.83) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.72 (0.63 - 0.83) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.72 (0.62 - 0.83) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.72 (0.61 - 0.83) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.72 (0.61 - 0.84) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.73 (0.62 - 0.86) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.75 (0.63 - 0.88) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.78 (0.65 - 0.92) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.81 (0.67 - 0.96) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.83 (0.68 - 1) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.86 (0.70 - 1.04) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.89 (0.73 - 1.09) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.93 (0.76 - 1.15) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.98 (0.80 - 1.21) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.03 (0.83 - 1.28) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.99 (0.82 - 1.23) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
Showing out of
Show more
People who inject drugs (PWID)
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
45.77 | 2017 | Survey/reported | EMCDDA; General Directorate of Health Service |
39.78 | 2015 | Survey/reported | EMCDDA; General Directorate of Health Service |
42.8 | 2014 | Survey/reported | EMCDDA; General Directorate of Health Service |
45.07 | 2013 | Survey/reported | EMCDDA; General Directorate of Health Service |
50.1 | 2012 | Survey/reported | EMCDDA; General Directorate of Health Service |
48.61 | 2011 | Survey/reported | EMCDDA; General Directorate of Health Service |
32.88 | 2010 | Survey/reported | EMCDDA; General Directorate of Health Service |
28.91 | 2009 | Survey/reported | EMCDDA; General Directorate of Health Service |
23.48 | 2008 | Survey/reported | EMCDDA; General Directorate of Health Service |
43.33 | 2007 | Survey/reported | EMCDDA; General Directorate of Health Service |
55.16 | 2006 | Survey/reported | EMCDDA; General Directorate of Health Service |
Showing out of
Show more
Women of childbearing age (15–49 years)
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0.29 (0.16 - 0.45) | 2019 | Modelled | Dugan et al., 2021 |
Prevalence of anti-HCV
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
1 | 2009 | Survey/reported | Zeynep F et al, 2008. |
0.3 | 2003 | Survey/reported | Ozsoy MF et al, 2003 |
1 (0.60 - 2.10) | 2014 | Survey/reported | Gower et al, 2014 |
0.95 | 2019 | Modelled | Jin et al. 2017 |
Showing out of
Show more
Men who have sex with men (MSM) Living with HIV
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0 (0 - 1.30) | 2019 | Modelled | Jin et al. 2017 |
Number of people living with chronic HCV (RNA+/cAg)
National
DownloadValue | Year | Type | Source |
---|---|---|---|
492,000 (271,000 - 763,000) | 2015 | Modelled | Blach et al, 2017 |
589,399 (479,308 - 728,557) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
570,988 (466,584 - 708,112) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
552,723 (452,166 - 682,311) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
536,066 (439,619 - 657,444) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
522,518 (429,363 - 635,170) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
513,788 (423,712 - 620,933) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
506,548 (422,410 - 603,500) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
496,780 (416,523 - 588,086) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
486,736 (410,257 - 572,549) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
479,192 (404,831 - 561,280) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
477,420 (403,624 - 558,709) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
480,560 (411,281 - 557,392) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
484,996 (419,688 - 561,200) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
490,874 (427,102 - 562,421) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
498,090 (433,631 - 566,658) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
506,754 (442,378 - 578,241) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
517,624 (452,385 - 590,501) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
530,090 (463,309 - 604,100) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
543,011 (475,183 - 618,129) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
555,140 (486,888 - 630,325) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
565,808 (495,345 - 643,438) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
577,090 (504,809 - 655,527) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
590,549 (515,487 - 672,236) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
605,660 (527,157 - 694,618) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
620,296 (536,093 - 713,465) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
632,484 (543,249 - 731,541) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
625,383 (529,330 - 727,919) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
623,031 (512,389 - 736,221) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
686,331 (562,900 - 826,735) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
815,142 (670,233 - 1,006,820) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
808,638 (664,031 - 999,651) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
Showing out of
Show more
Women of childbearing age (15–49 years)
DownloadValue | Year | Type | Source |
---|---|---|---|
63,500 (35,000 - 98,500) | 2019 | Modelled | Dugan et al., 2021 |
HCV-related death rate
National
DownloadValue (Deaths per 100,000) | Year | Type | Source |
---|---|---|---|
3.22 (2.35 - 4.29) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
2.83 (1.89 - 3.74) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.77 (1.88 - 3.65) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.68 (1.89 - 3.49) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.71 (1.89 - 3.57) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.67 (1.89 - 3.44) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.65 (1.93 - 3.39) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.62 (1.92 - 3.34) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.62 (1.94 - 3.29) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.64 (1.97 - 3.33) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.44 (1.87 - 2.99) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.55 (1.93 - 3.18) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.49 (1.93 - 3.06) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.45 (1.91 - 3) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.38 (1.81 - 2.99) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.32 (1.76 - 2.97) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.32 (1.75 - 2.95) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.57 (1.94 - 3.26) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.42 (1.83 - 3.09) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.28 (1.73 - 2.91) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.69 (2.10 - 3.38) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.77 (2.20 - 3.46) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.8 (2.24 - 3.52) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.8 (2.23 - 3.49) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.82 (2.23 - 3.48) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.85 (2.20 - 3.53) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.84 (2.24 - 3.49) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
2.96 (2.25 - 3.76) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.1 (2.33 - 4.04) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.16 (2.33 - 4.10) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
3.22 (2.35 - 4.29) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
HCV-related deaths
National
DownloadValue | Year | Type | Source |
---|---|---|---|
2,492 | 2016 | Modelled | WHO |
2,624 (1,910 - 3,491) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,624 (1,910 - 3,491) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
2,558 (1,891 - 3,326) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,501 (1,883 - 3,262) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,371 (1,804 - 3,012) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,258 (1,742 - 2,802) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,225 (1,756 - 2,739) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,181 (1,722 - 2,691) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,131 (1,700 - 2,656) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,114 (1,689 - 2,654) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,071 (1,644 - 2,587) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,003 (1,564 - 2,516) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,898 (1,438 - 2,413) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,777 (1,348 - 2,272) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,691 (1,277 - 2,151) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,651 (1,253 - 2,112) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,668 (1,267 - 2,139) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,701 (1,294 - 2,130) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,757 (1,364 - 2,162) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,712 (1,334 - 2,096) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,688 (1,293 - 2,070) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,750 (1,322 - 2,178) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,770 (1,314 - 2,228) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,763 (1,313 - 2,222) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,730 (1,265 - 2,202) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,725 (1,254 - 2,201) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,709 (1,209 - 2,201) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,686 (1,192 - 2,201) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,680 (1,172 - 2,215) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,688 (1,145 - 2,224) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,689 (1,127 - 2,238) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
Percent of liver cancer deaths attributable to HCV
National
Download
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
DownloadValue | Year | Type | Source |
---|---|---|---|
0 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
HBV National Action Plan
HBV elimination goal
HBV testing policy
Pregnant women, Risk-based
HepB birth dose policy
Yes
Year of birth dose introduction
2003
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
HCV testing policy
Risk-based
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)
Overview
HBV elimination goal
HCV elimination goal
Prevalence (national)
Modelled
Survey/surveillance
Hepatitis related deaths (national)
Modelled
HBV
3,530
2019
(2,645 - 4,618)
IHME, GBD 2019 (accessed 2022)
Survey/surveillance
No data available
HBV chart
Modelled
HCV
2,624
2019
(1,910 - 3,491)
IHME, GBD 2019 (accessed 2022)
Survey/surveillance
No data available
HCV chart
Prevalence < 5
HBV
0.11
(%)
2020, latest modelled
(0.09 - 0.13(%))
WHO
Prevalence PWID
No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines